Huertgenwald, Germany

Andreas Fischer

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Endo Pharmaceuticals Inc., Grunenthal Gmbh. Active years: 2015-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Fischer. Retrieved from https://idiyas.com/inventor/andreas-fischer-ulb5p7am

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Andreas Fischer

Introduction

Andreas Fischer is a notable inventor based in Hürtgenwald, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative forms of oxymorphone hydrochloride. With a total of three patents to his name, Fischer's work has the potential to impact pain management therapies.

Latest Patents

Fischer's latest patents focus on crystalline, anhydrous forms of oxymorphone hydrochloride. These patents disclose crystalline, anhydrous hydrochloride salts of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one (oxymorphone) and report three polymorphic forms of these salts. The inventions also relate to methods for producing such salts and pharmaceutical compositions that include effective amounts of these salts as medicaments for the treatment and/or prevention of pain.

Career Highlights

Throughout his career, Andreas Fischer has worked with prominent companies in the pharmaceutical industry, including Endo Pharmaceuticals Inc. and Grünenthal GmbH. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Fischer has collaborated with several professionals in his field, including Dagmar Peters-Groth and Dagmar Lischke. These collaborations have likely enhanced his research and development efforts.

Conclusion

Andreas Fischer's contributions to pharmaceutical innovations, particularly in the area of oxymorphone hydrochloride, demonstrate his commitment to advancing pain management solutions. His patents and collaborations reflect a dedication to improving therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…